Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B.
Greenberg LA.
Prim Care. 2024 Sep;51(3):483-494. doi: 10.1016/j.pop.2024.03.006. Epub 2024 May 23.
Multiple endocrine neoplasia.
White ML, Doherty GM.
Surg Oncol Clin N Am. 2008 Apr;17(2):439-59, x. doi: 10.1016/j.soc.2007.12.002.
[Multiple endocrine neoplasia type 2A in a family].
Hircsu I, Gazdag A, Bodor M, Berta E, Andrási M, Kanyári Z, Győry F, Barna S, Bhattoa HP, Nagy B, Nagy VE, Erdei A.
Orv Hetil. 2020 Jan;161(2):75-79. doi: 10.1556/650.2020.31595.
The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes.
Moley JF.
Annu Rev Med. 1997;48:409-20. doi: 10.1146/annurev.med.48.1.409.
Update on multiple endocrine neoplasia Type 1 and 2.
Al-Salameh A, Baudry C, Cohen R.
Presse Med. 2018 Sep;47(9):722-731. doi: 10.1016/j.lpm.2018.03.005. Epub 2018 Jun 13.
Non-mammalian models of multiple endocrine neoplasia type 2.
Das TK, Cagan RL.
Endocr Relat Cancer. 2018 Feb;25(2):T91-T104. doi: 10.1530/ERC-17-0411.
Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Tsang VH, Tacon LJ, Learoyd DL, Robinson BG.
Recent Results Cancer Res. 2015;204:157-78. doi: 10.1007/978-3-319-22542-5_7.
Multiple endocrine neoplasia type 2: an overview.
Moline J, Eng C.
Genet Med. 2011 Sep;13(9):755-64. doi: 10.1097/GIM.0b013e318216cc6d.
The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2.
Moodley S, Weber F, Mulligan LM.
Endocr Relat Cancer. 2018 Feb;25(2):E1-E4. doi: 10.1530/ERC-17-0488.
Preimplantation Genetic Testing of Multiple Endocrine Neoplasia Type 2A.
Würgler Hansen A, Sønderberg Roos LK, Løssl K, Godballe C, Mathiesen JS.
Front Endocrinol (Lausanne). 2020 Oct 14;11:572151. doi: 10.3389/fendo.2020.572151. eCollection 2020.
